Latest media releases
UBS Warburg Names Sanjiv Arora Medical Technology Analyst
UBS Warburg announced today that Sanjiv Arora will join the firm as senior medical technology analyst. Mr. Arora will be an executive director and will report to Raul Esquivel, director of U.S. Research.
"Sanjiv has more than 15 years of experience and an in-depth knowledge of the medical technology sector." said Mr. Esquivel. "He will be a valuable addition to our healthcare group and will work closely with all members of our global team," Mr. Esquivel added.
Prior to joining UBS Warburg, Mr. Arora was a managing director and senior analyst in the Healthcare Medical Technology Group at RBC Capital. Before that, he was a product manager in the cardiology division at SCIMED Life Systems Inc. In 1998 and 1999 Mr. Arora was ranked first in Institutional Investor's "Best of Boutiques Poll."
UBS Warburg is the investment banking group of UBS AG (NYSE: UBS), one of the largest financial services firms in the world with 71,000 employees in more than 40 countries. UBS Warburg is a leader in equities, corporate finance, M&A advisory and financing, financial structuring, fixed income issuance and trading, foreign exchange, derivatives and risk management.
CONTACT: Kris Kagel of UBS Warburg, +1-212-713-8703
Products and services in these webpages may not be available for residents of certain nations. Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998 - 2014. All rights reserved.